GL-IL2-138

N/A

Report date: 2025/08/13 17:43:00
NME

Base Information

Drug NameGL-IL2-138
Drug Alias NameGL-IL2-138
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionInterleukin-2 modulators
TargetsInterleukin-2
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenetic Leap
China Registration ClassN/A

Develop Information

Active CompaniesGenetic Leap
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A